Renaissance Technologies - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2022$1,278,000
-67.8%
18,386
-61.7%
0.00%
-60.0%
Q1 2022$3,975,000
-70.4%
47,975
-73.2%
0.01%
-70.6%
Q4 2021$13,446,000
-45.9%
179,091
-16.3%
0.02%
-46.9%
Q3 2021$24,857,000
-50.6%
213,975
-5.6%
0.03%
-49.2%
Q2 2021$50,303,000
-6.9%
226,775
-44.5%
0.06%
-6.0%
Q1 2021$54,005,000
+4.7%
408,575
+37.1%
0.07%
+19.6%
Q4 2020$51,561,000
-52.6%
297,970
-69.5%
0.06%
-48.6%
Q3 2020$108,824,000
-8.3%
977,670
-51.1%
0.11%
+6.9%
Q2 2020$118,634,000
-21.5%
2,000,570
-10.9%
0.10%
-30.6%
Q1 2020$151,210,000
-20.0%
2,245,470
+0.2%
0.15%
+1.4%
Q4 2019$188,933,000
+6.3%
2,241,995
-5.6%
0.14%
-3.3%
Q3 2019$177,660,000
+36.7%
2,375,770
+15.6%
0.15%
+31.6%
Q2 2019$129,967,000
+45.3%
2,055,470
+10.7%
0.11%
+40.7%
Q1 2019$89,417,000
+149.5%
1,856,270
+73.4%
0.08%
+107.7%
Q4 2018$35,839,000
-18.5%
1,070,470
+27.6%
0.04%
-13.3%
Q3 2018$43,974,000
+73.7%
839,195
-2.9%
0.04%
+221.4%
Q2 2018$25,320,000
+540.2%
864,003
+376.3%
0.01%
+250.0%
Q1 2018$3,955,000
-23.6%
181,400
-29.2%
0.00%
-33.3%
Q4 2017$5,177,000256,2750.01%
Other shareholders
NOVOCURE LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders